273 related articles for article (PubMed ID: 20631012)
1. Obesity-linked variants of melanocortin-4 receptor are misfolded in the endoplasmic reticulum and can be rescued to the cell surface by a chemical chaperone.
Granell S; Mohammad S; Ramanagoudr-Bhojappa R; Baldini G
Mol Endocrinol; 2010 Sep; 24(9):1805-21. PubMed ID: 20631012
[TBL] [Abstract][Full Text] [Related]
2. A novel melanocortin-4 receptor mutation MC4R-P272L associated with severe obesity has increased propensity to be ubiquitinated in the ER in the face of correct folding.
Granell S; Serra-Juhé C; Martos-Moreno GÁ; Díaz F; Pérez-Jurado LA; Baldini G; Argente J
PLoS One; 2012; 7(12):e50894. PubMed ID: 23251400
[TBL] [Abstract][Full Text] [Related]
3. The cytosolic chaperone Hsc70 promotes traffic to the cell surface of intracellular retained melanocortin-4 receptor mutants.
Meimaridou E; Gooljar SB; Ramnarace N; Anthonypillai L; Clark AJ; Chapple JP
Mol Endocrinol; 2011 Sep; 25(9):1650-60. PubMed ID: 21719532
[TBL] [Abstract][Full Text] [Related]
4. Exposure of MC4R to agonist in the endoplasmic reticulum stabilizes an active conformation of the receptor that does not desensitize.
Granell S; Molden BM; Baldini G
Proc Natl Acad Sci U S A; 2013 Dec; 110(49):E4733-42. PubMed ID: 24248383
[TBL] [Abstract][Full Text] [Related]
5. Rescue of defective MC4R cell-surface expression and signaling by a novel pharmacoperone Ipsen 17.
Wang XH; Wang HM; Zhao BL; Yu P; Fan ZC
J Mol Endocrinol; 2014 Aug; 53(1):17-29. PubMed ID: 24780838
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity.
René P; Le Gouill C; Pogozheva ID; Lee G; Mosberg HI; Farooqi IS; Valenzano KJ; Bouvier M
J Pharmacol Exp Ther; 2010 Dec; 335(3):520-32. PubMed ID: 20826565
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological chaperone action in humanized mouse models of MC4R-linked obesity.
René P; Lanfray D; Richard D; Bouvier M
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434184
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological chaperones increase the cell-surface expression of intracellularly retained mutants of the melanocortin 4 receptor with unique rescuing efficacy profiles.
Ward NA; Hirst S; Williams J; Findlay JB
Biochem Soc Trans; 2012 Aug; 40(4):717-20. PubMed ID: 22817722
[TBL] [Abstract][Full Text] [Related]
9. Mild lipid stress induces profound loss of MC4R protein abundance and function.
Cragle FK; Baldini G
Mol Endocrinol; 2014 Mar; 28(3):357-67. PubMed ID: 24506538
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological chaperones for the misfolded melanocortin-4 receptor associated with human obesity.
Huang H; Wang W; Tao YX
Biochim Biophys Acta Mol Basis Dis; 2017 Oct; 1863(10 Pt A):2496-2507. PubMed ID: 28284973
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity.
Tao YX; Segaloff DL
Endocrinology; 2003 Oct; 144(10):4544-51. PubMed ID: 12959994
[TBL] [Abstract][Full Text] [Related]
12. Maternal high-fat diet induces metabolic stress response disorders in offspring hypothalamus.
Nguyen LT; Saad S; Tan Y; Pollock C; Chen H
J Mol Endocrinol; 2017 Jul; 59(1):81-92. PubMed ID: 28500249
[TBL] [Abstract][Full Text] [Related]
13. Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress.
Kubota K; Niinuma Y; Kaneko M; Okuma Y; Sugai M; Omura T; Uesugi M; Uehara T; Hosoi T; Nomura Y
J Neurochem; 2006 Jun; 97(5):1259-68. PubMed ID: 16539653
[TBL] [Abstract][Full Text] [Related]
14. A small molecule agonist THIQ as a novel pharmacoperone for intracellularly retained melanocortin-4 receptor mutants.
Huang H; Tao YX
Int J Biol Sci; 2014; 10(8):817-24. PubMed ID: 25076858
[TBL] [Abstract][Full Text] [Related]
15. Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis.
Vilatoba M; Eckstein C; Bilbao G; Smyth CA; Jenkins S; Thompson JA; Eckhoff DE; Contreras JL
Surgery; 2005 Aug; 138(2):342-51. PubMed ID: 16153446
[TBL] [Abstract][Full Text] [Related]
16. [Molecular pharmacological studies on the protection mechanism against endoplasmic reticulum stress-induced neurodegenerative disease].
Kaneko M
Yakugaku Zasshi; 2012; 132(12):1437-42. PubMed ID: 23208051
[TBL] [Abstract][Full Text] [Related]
17. Signal pathway analysis of selected obesity-associated melanocortin-4 receptor class V mutants.
Sharma S; Thibodeau S; Lytton J
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165835. PubMed ID: 32423884
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients.
Fan ZC; Tao YX
J Cell Mol Med; 2009 Sep; 13(9B):3268-82. PubMed ID: 19298524
[TBL] [Abstract][Full Text] [Related]
19. 4-Phenylbutyrate suppresses the unfolded protein response without restoring protein folding in Saccharomyces cerevisiae.
Mai CT; Le QG; Ishiwata-Kimata Y; Takagi H; Kohno K; Kimata Y
FEMS Yeast Res; 2018 Mar; 18(2):. PubMed ID: 29452364
[TBL] [Abstract][Full Text] [Related]
20. Deletion of codons 88-92 of the melanocortin-4 receptor gene: a novel deleterious mutation in an obese female.
Donohoue PA; Tao YX; Collins M; Yeo GS; O'Rahilly S; Segaloff DL
J Clin Endocrinol Metab; 2003 Dec; 88(12):5841-5. PubMed ID: 14671178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
